Investment Stage

Focus Areas

About Investor

Kevin Chu is a Principal at F-Prime Capital Partners specializing in BioTech and Medical Device investments. Based in California, he focuses on companies advancing healthcare through innovative therapeutics, diagnostics, and medical technologies. Kevin works with startups at the Seed, Series A, and Series B stages, helping them scale and navigate key growth milestones. He seeks opportunities where scientific innovation can generate meaningful clinical and commercial impact. His typical investment range is between $2 million and $10 million, with an average investment size of roughly $6 million. Founders developing transformative healthcare technologies would likely fit well within his investment mandate.